5NP0 Stock Chart & Stats
€0.01
€0.00(0.00%)
At close: 4:00 PM EDT
€0.01
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.01 - €0.01
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€478.10K
Enterprise Value€487.77K
Total Cash (Recent Filing)€13.99K
Total Debt (Recent Filing)€26.23K
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-194.15
Shares Outstanding25,646,020
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)5.79
Price to Sales (P/S)0.00
P/FCF Ratio-7.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
5NP0 FAQ
What was HAVN Life Sciences’s price range in the past 12 months?
HAVN Life Sciences lowest stock price was €0.01 and its highest was €0.01 in the past 12 months.
What is HAVN Life Sciences’s market cap?
HAVN Life Sciences’s market cap is €478.10K.
When is HAVN Life Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HAVN Life Sciences’s earnings last quarter?
Currently, no data Available
Is HAVN Life Sciences overvalued?
According to Wall Street analysts HAVN Life Sciences’s price is currently Overvalued.
Does HAVN Life Sciences pay dividends?
HAVN Life Sciences does not currently pay dividends.
What is HAVN Life Sciences’s EPS estimate?
HAVN Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HAVN Life Sciences have?
HAVN Life Sciences has 25,646,020 shares outstanding.
What happened to HAVN Life Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HAVN Life Sciences?
Currently, no hedge funds are holding shares in DE:5NP0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HAVN Life Sciences
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.